These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
429 related items for PubMed ID: 12759801
21. Brain serotonin synthesis in MDMA (ecstasy) polydrug users: an alpha-[(11) C]methyl-l-tryptophan study. Booij L, Soucy JP, Young SN, Regoli M, Gravel P, Diksic M, Leyton M, Pihl RO, Benkelfat C. J Neurochem; 2014 Dec; 131(5):634-44. PubMed ID: 25041501 [Abstract] [Full Text] [Related]
23. Depression, impulsiveness, sleep, and memory in past and present polydrug users of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy). Taurah L, Chandler C, Sanders G. Psychopharmacology (Berl); 2014 Feb; 231(4):737-51. PubMed ID: 24114426 [Abstract] [Full Text] [Related]
24. The effect of acute tryptophan depletion on mood and impulsivity in polydrug ecstasy users. Young SN, Regoli M, Leyton M, Pihl RO, Benkelfat C. Psychopharmacology (Berl); 2014 Feb; 231(4):707-16. PubMed ID: 24142202 [Abstract] [Full Text] [Related]
25. Memory deficits in abstinent MDMA (ecstasy) users: neuropsychological evidence of frontal dysfunction. Quednow BB, Jessen F, Kuhn KU, Maier W, Daum I, Wagner M. J Psychopharmacol; 2006 May; 20(3):373-84. PubMed ID: 16574711 [Abstract] [Full Text] [Related]
26. Discrete memory impairments in largely pure chronic users of MDMA. Wunderli MD, Vonmoos M, Fürst M, Schädelin K, Kraemer T, Baumgartner MR, Seifritz E, Quednow BB. Eur Neuropsychopharmacol; 2017 Oct; 27(10):987-999. PubMed ID: 28866005 [Abstract] [Full Text] [Related]
27. Preliminary evidence of hippocampal dysfunction in adolescent MDMA ("ecstasy") users: possible relationship to neurotoxic effects. Jacobsen LK, Mencl WE, Pugh KR, Skudlarski P, Krystal JH. Psychopharmacology (Berl); 2004 May; 173(3-4):383-90. PubMed ID: 14647960 [Abstract] [Full Text] [Related]
28. Patterns of drug use and the influence of gender on self-reports of memory ability in ecstasy users: a web-based study. Rodgers J, Buchanan T, Scholey AB, Heffernan TM, Ling J, Parrott AC. J Psychopharmacol; 2003 Dec; 17(4):389-96. PubMed ID: 14870950 [Abstract] [Full Text] [Related]
29. Chronic MDMA (ecstasy) use, cognition and mood. McCardle K, Luebbers S, Carter JD, Croft RJ, Stough C. Psychopharmacology (Berl); 2004 May; 173(3-4):434-9. PubMed ID: 15088077 [Abstract] [Full Text] [Related]
30. A prospective study of learning, memory, and executive function in new MDMA users. Wagner D, Becker B, Koester P, Gouzoulis-Mayfrank E, Daumann J. Addiction; 2013 Jan; 108(1):136-45. PubMed ID: 22831704 [Abstract] [Full Text] [Related]
31. Empathy and aggression: two faces of ecstasy? A study of interpretative cognitive bias and mood change in ecstasy users. Curran HV, Rees H, Hoare T, Hoshi R, Bond A. Psychopharmacology (Berl); 2004 May; 173(3-4):425-33. PubMed ID: 14735288 [Abstract] [Full Text] [Related]
32. Auditory event-related potentials (P3) and cognitive performance in recreational ecstasy polydrug users: evidence from a 12-month longitudinal study. de Sola S, Tarancón T, Peña-Casanova J, Espadaler JM, Langohr K, Poudevida S, Farré M, Verdejo-García A, de la Torre R. Psychopharmacology (Berl); 2008 Oct; 200(3):425-37. PubMed ID: 18581098 [Abstract] [Full Text] [Related]
33. Impaired cognitive performance in drug free users of recreational ecstasy (MDMA). Gouzoulis-Mayfrank E, Daumann J, Tuchtenhagen F, Pelz S, Becker S, Kunert HJ, Fimm B, Sass H. J Neurol Neurosurg Psychiatry; 2000 Jun; 68(6):719-25. PubMed ID: 10811694 [Abstract] [Full Text] [Related]
34. Neural mechanisms of working memory in ecstasy (MDMA) users who continue or discontinue ecstasy and amphetamine use: evidence from an 18-month longitudinal functional magnetic resonance imaging study. Daumann J, Fischermann T, Heekeren K, Thron A, Gouzoulis-Mayfrank E. Biol Psychiatry; 2004 Sep 01; 56(5):349-55. PubMed ID: 15336517 [Abstract] [Full Text] [Related]
35. Reduced memory skills and increased hair cortisol levels in recent Ecstasy/MDMA users: significant but independent neurocognitive and neurohormonal deficits. Downey LA, Sands H, Jones L, Clow A, Evans P, Stalder T, Parrott AC. Hum Psychopharmacol; 2015 May 01; 30(3):199-207. PubMed ID: 25900184 [Abstract] [Full Text] [Related]
36. Angry cognitive bias, trait aggression and impulsivity in substance users. Bond AJ, Verheyden SL, Wingrove J, Curran HV. Psychopharmacology (Berl); 2004 Jan 01; 171(3):331-9. PubMed ID: 13680074 [Abstract] [Full Text] [Related]
37. Neurocognitive function in current and ex-users of ecstasy in comparison to both matched polydrug-using controls and drug-naïve controls. Hoshi R, Mullins K, Boundy C, Brignell C, Piccini P, Curran HV. Psychopharmacology (Berl); 2007 Oct 01; 194(3):371-9. PubMed ID: 17605005 [Abstract] [Full Text] [Related]
38. MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress. Parrott AC. J Psychopharmacol; 2006 Mar 01; 20(2):147-63. PubMed ID: 16510474 [Abstract] [Full Text] [Related]
39. Altered neuroendocrine and behavioral responses to m-chlorophenylpiperazine in 3,4-methylenedioxymethamphetamine (MDMA) users. McCann UD, Eligulashvili V, Mertl M, Murphy DL, Ricaurte GA. Psychopharmacology (Berl); 1999 Nov 01; 147(1):56-65. PubMed ID: 10591869 [Abstract] [Full Text] [Related]
40. The harmful health effects of recreational ecstasy: a systematic review of observational evidence. Rogers G, Elston J, Garside R, Roome C, Taylor R, Younger P, Zawada A, Somerville M. Health Technol Assess; 2009 Jan 01; 13(6):iii-iv, ix-xii, 1-315. PubMed ID: 19195429 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]